Fig. 3From: Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)Illustrates the substitution of red blood cells (RBCs). Within the first 30Â days, a blood transfusion with RBCs was required in approximately one of every five (21.0%) patients. Significantly more RBCs had to be administered to patients with AFBack to article page